Position in ACB
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$22,322
+$12,802 QoQ
Shares Held
8,001
+300.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 149 holders
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MCDONALD PARTNERS LLC holds $423,482 across 7 Drug Manufacturers - Specialty & Generic names. ACB ranks #2 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,184 | $372,522 | |
| 2 | ACB |
Aurora Cannabis Inc
This page
|
8,001 | $22,322 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
600 | $14,766 | |
| 4 | HLN |
Haleon plc
|
750 | $6,997 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
400 | $6,412 | |
| 6 | VTRS |
Viatris Inc
|
26 | $412 | |
| 7 | OGI |
Organigram Global Inc.
|
50 | $51 |
All Filings in ACB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,322 | 8,001 | Shares | Sole | 2026-07-28 | |
| 2023-12-31 | $9,520 | 20,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $8,775 | 15,000 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $5,350 | 10,000 | Shares | Sole | 2023-07-17 | |
| 2021-12-31 | $378 | 70 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||